BioRestorative Therapies, Inc.
NASDAQ · us_market
No AI summary generated yet for this ticker.
BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells. The company develops programs related to the treatment of disc/spine disease and metabolic disorders. Its products pipeline comprises BRTX-100, a lead cell therapy candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, as well as used for the non-surgical treatment of painful lumbosacral disc disorders or as a complimentary therapeutic to a surgical procedure; and ThermoStem, a cell-based therapy candidate to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. The company also operates a commercial biocosmeceutical platform. In addition, it provides investigational curved needle device to deliver cells and/or other therapeutic products or material to the spine and discs, and other parts of the body. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. BioRestorative Therapies, Inc. is headquartered in Melville, New York.
Which stocks have an unusual volume on Thursday?
Let's have a look at what is happening on the US markets one hour before the close of the markets on Wednesday. Below you can find the top gainers and losers in today's session.
Stay updated with the latest market activity on Wednesday. Explore the most active stocks in today's session and stay informed about the stocks that are in the spotlight.
Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top gainers and losers in today's session.
Before the opening bell on Wednesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
US stocks mixed, Dow up 300 pts. Dow up 0.64%, NASDAQ down 0.34%. Consumer discretionary up 1.7%, energy down 1.9%. DKS stock falls 5% on mixed results.
Urgently seeks meeting with the BRTX Board to discuss opportunities to unlock value for all shareholdersMIAMI, May 27, 2026 /CNW/ - Kaos Capital Ltd. ("Kaos Capital" or "we"), a Miami-based hedge fund focused on activist
Healthcare stocks were lower Tuesday afternoon, with the NYSE Healthcare Index shedding 0.6% and the
BioRestorative Therapies, Inc. ("BioRestorative," "BRTX," or the "Company") (NASDAQ:BRTX), a late-stage clinical regenerative medicine company focused on stem cell-based therapies and products, today announced that the
Biorestorative Therapies (BRTX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Biorestorative Therapies (BRTX) delivered earnings and revenue surprises of +36.67% and -53.66%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
9,046,242 Common Stock of BioRestorative Therapies, Inc. are subject to a Lock-Up Agreement Ending on 15-MAY-2026. These Common Stock will be under lockup for 91 days starting from 13-FEB-2026 to...
Certain Series B Preferred Stock of BioRestorative Therapies, Inc. are subject to a Lock-Up Agreement Ending on 15-MAY-2026. These Series B Preferred Stock will be under lockup for 91 days starting...
Certain Warrants of BioRestorative Therapies, Inc. are subject to a Lock-Up Agreement Ending on 15-MAY-2026. These Warrants will be under lockup for 91 days starting from 13-FEB-2026 to...
Certain Options of BioRestorative Therapies, Inc. are subject to a Lock-Up Agreement Ending on 15-MAY-2026. These Options will be under lockup for 91 days starting from 13-FEB-2026 to...
Data demonstrate distinct functional signatures across MSC-derived extracellular vesicles supporting targeted regenerative and aesthetic applicationsMELVILLE, N.Y., May 13, 2026 (GLOBE NEWSWIRE) -- BioRestorative
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| StateStreet | passive | 32.5K | $8.83K | 0.00% | Unchanged | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-05-14 | -0.30 | -0.12 | +60.00% |
| 2026-03-26 | -0.37 | -0.32 | +13.51% |
| 2025-11-12 | -0.38 | -0.33 | +13.16% |
| 2025-08-12 | -0.41 | -0.30 | +26.83% |
| 2025-05-14 | -0.32 | -0.64 | -100.00% |
| 2025-03-28 | -0.27 | -0.09 | +65.52% |
| 2024-11-12 | -0.35 | -0.01 | +98.07% |
| 2024-08-13 | -0.56 | -0.28 | +49.61% |
| 2024-06-11 | -0.51 | -0.59 | -15.65% |
| 2024-04-01 | -0.65 | -0.57 | +12.31% |
| 2023-11-13 | -0.68 | -0.64 | +5.88% |
| 2023-08-11 | -1.56 | -0.77 | +50.64% |
| 2023-05-12 | -1.26 | -1.53 | -21.43% |
| 2023-03-27 | -1.35 | -1.18 | +12.59% |
| 2022-11-14 | -1.45 | -1.28 | +11.72% |
| 2022-05-16 | -0.63 | -1.37 | -117.46% |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| BRTX | +104.89% | +129.48% | -59.32% | -72.76% |
| XLV | +2.97% | -4.64% | -3.44% | +12.69% |
| Alpha (stock − sector) | +101.92% | +134.11% | -55.88% | -85.45% |